Search for a command to run...
Remedium Lifecare Ltd. significantly underperforms its peers in growth, profitability, and valuation metrics, making it a laggard in the trading industry. With no revenue growth and high PE ratio, it lacks financial stability compared to its peers, which exhibit varying degrees of profitability and growth.
Stocks | CMP | Market Cap | P/E | ROCE (%) | Debt/Equity |
---|---|---|---|---|---|
Remedium Lifecare Ltd. | ₹1.39 | ₹56.04Cr | 80.35 | - | - |
ADANIENT | ₹2,283.00 | ₹2,63,499.29Cr | 43.53 | 11.81% | 1.45 |
REDINGTON | ₹243.85 | ₹19,063.56Cr | 13.20 | 23.63% | 0.37 |
CPPLUS | ₹1,246.40 | ₹14,610.54Cr | 107.99 | 41.16% | 0.46 |
CELLO | ₹535.15 | ₹11,820.66Cr | 120.15 | 43.92% | 0.32 |
HONASA | ₹298.95 | ₹9,721.38Cr | 151.70 | 8.99% | - |
MMTC | ₹62.18 | ₹9,327.00Cr | 134.15 | 6.90% | - |